These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31551935)

  • 1. Targeting Endothelin-1 Receptor/β-Arrestin-1 Axis in Ovarian Cancer: From Basic Research to a Therapeutic Approach.
    Tocci P; Rosanò L; Bagnato A
    Front Endocrinol (Lausanne); 2019; 10():609. PubMed ID: 31551935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer.
    Rosanò L; Cianfrocca R; Sestito R; Tocci P; Di Castro V; Bagnato A
    Expert Opin Ther Targets; 2017 Oct; 21(10):925-932. PubMed ID: 28758529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP and endothelin-1 signaling: an emerging alliance in cancer.
    Tocci P; Blandino G; Bagnato A
    J Exp Clin Cancer Res; 2021 Jan; 40(1):27. PubMed ID: 33422090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy.
    Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Caprara V; Semprucci E; Ferrandina G; Natali PG; Bagnato A
    Cancer Res; 2014 Dec; 74(24):7453-64. PubMed ID: 25377471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-arrestin1 at the cross-road of endothelin-1 signaling in cancer.
    Rosanò L; Bagnato A
    J Exp Clin Cancer Res; 2016 Jul; 35(1):121. PubMed ID: 27473335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer.
    Chellini L; Caprara V; Spadaro F; Sestito R; Bagnato A; Rosanò L
    Matrix Biol; 2019 Aug; 81():17-33. PubMed ID: 30367951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer.
    Cianfrocca R; Rosanò L; Tocci P; Sestito R; Caprara V; Di Castro V; De Maria R; Bagnato A
    Cell Death Differ; 2017 Oct; 24(10):1811-1820. PubMed ID: 28708138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods to Investigate β-Arrestin-1/β-Catenin Signaling in Ovarian Cancer Cells.
    Rosanò L; Cianfrocca R; Bagnato A
    Methods Mol Biol; 2019; 1957():393-406. PubMed ID: 30919368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1/endothelin A receptor axis activates RhoA GTPase in epithelial ovarian cancer.
    Tocci P; Caprara V; Cianfrocca R; Sestito R; Di Castro V; Bagnato A; Rosanò L
    Life Sci; 2016 Aug; 159():49-54. PubMed ID: 26776837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.
    Di Modugno F; Caprara V; Chellini L; Tocci P; Spadaro F; Ferrandina G; Sacconi A; Blandino G; Nisticò P; Bagnato A; Rosanò L
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):3132-3137. PubMed ID: 29439204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin therapeutics in cancer: Where are we?
    Rosanò L; Bagnato A
    Am J Physiol Regul Integr Comp Physiol; 2016 Mar; 310(6):R469-75. PubMed ID: 26818060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer.
    Tocci P; Cianfrocca R; Di Castro V; Rosanò L; Sacconi A; Donzelli S; Bonfiglio S; Bucci G; Vizza E; Ferrandina G; Scambia G; Tonon G; Blandino G; Bagnato A
    Nat Commun; 2019 Jul; 10(1):3196. PubMed ID: 31324767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis.
    Teoh JP; Park KM; Wang Y; Hu Q; Kim S; Wu G; Huang S; Maihle N; Kim IM
    Cell Signal; 2014 Dec; 26(12):2885-95. PubMed ID: 25194819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells.
    Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L
    Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma.
    Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L
    Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling.
    Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Spadaro F; Salvati E; Biroccio AM; Natali PG; Bagnato A
    Oncogene; 2013 Oct; 32(42):5066-77. PubMed ID: 23208497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 axis fosters YAP-induced chemotherapy escape in ovarian cancer.
    Tocci P; Cianfrocca R; Sestito R; Rosanò L; Di Castro V; Blandino G; Bagnato A
    Cancer Lett; 2020 Nov; 492():84-95. PubMed ID: 32860850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer.
    Masi I; Ottavi F; Del Rio D; Caprara V; Vastarelli C; Giannitelli SM; Fianco G; Mozetic P; Buttarelli M; Ferrandina G; Scambia G; Gallo D; Rainer A; Bagnato A; Spadaro F; Rosanò L
    Cell Death Dis; 2023 Jan; 14(1):73. PubMed ID: 36717550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endothelin axis as therapeutic target in human malignancies: present and future.
    Bagnato A
    Curr Pharm Des; 2012; 18(19):2720-33. PubMed ID: 22390759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macitentan blocks endothelin-1 receptor activation required for chemoresistant ovarian cancer cell plasticity and metastasis.
    Sestito R; Cianfrocca R; Rosanò L; Tocci P; Di Castro V; Caprara V; Bagnato A
    Life Sci; 2016 Aug; 159():43-48. PubMed ID: 26776834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.